ATOSIBAN IN PREVENTION OF PREMATURE BIRTH - CLINICAL ASPECTS
Keywords:
atosiban, premature birth, preventionAbstract
Preterm birth is a leading cause of neonatal morbidity and mortality. Tocolytic therapy plays a key role in delaying delivery, in order to allow the use of corticosteroids and improve neonatal outcome. Atosiban, as a selective antagonist of oxytocin receptors, is used as one of the modern tocolytics with a favorable safety profile.
Objective: The paper aims to analyze the clinical application and outcomes of the use of atosiban in the prevention of preterm birth in patients treated in peripartum intensive care.
Materials and methods: This paper presents a retrospective analysis of patients treated with atosiban over a two-year period, in the peripartum intensive care unit of the PHI “GAK”-Skopje. The number of doses administered, gestational week at admission, type of pregnancy and pregnancy outcome were analyzed.
Results: Over a two-year period, 192 patients were treated with atosiban. The most common gestational week for administration was 32 and 33 weeks, respectively. Singleton pregnancies predominated over twin pregnancies. According to the outcome, patients were discharged from the hospital, and according to the mode of delivery, cesarean section was more common than spontaneous delivery.
Conclusion: Atosiban shows significant efficacy in delaying preterm birth, especially when applied in early treatment protocols and at an optimal gestational period. Its use allows stabilization of a significant number of patients and potentially improves perinatal outcome. Further studies are needed for a more detailed evaluation of long-term effects and comparison with other tocolytic agents
References
Dewan, Bhupesh & Shinde, Siddheshwar. (2023). Clinical safety and efficacy of atosiban brief duration 14-hour treatment regimen in delaying preterm labor. International Journal of Reproduction Contraception Obstetrics and Gynecology. 12. 1862-1865. 10.18203/2320-1770.ijrcog20231569
Gondane, P., Kumbhakarn, S., Maity, P., & Kapat, K. (2024). Recent Advances and Challenges in the Early Diagnosis and Treatment of Preterm Labor. Bioengineering, 11(2), 161. https://doi.org/10.3390/bioengineering11020161
Hossain, M. R., Paul, M., Tolosa, J. M., Smith, R., & Paul, J. W. (2025). Preventing Preterm Birth: The Search for Tocolytic Synergism. Reproductive sciences (Thousand Oaks, Calif.), 32(10), 3262–3286. https://doi.org/10.1007/s43032-025-01941-4
Kim, S.H., Riaposova, L., Ahmed, H. et al. (2019). Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium. Sci Rep 9, 5792.
Li, Y. X., Wei, S. Q., & Zheng, P. S. (2025). Atosiban-conjugated 3WJ-pRNA nanoparticles delivering GAS1-enhanced extracellular vesicles: targeting the decidua to combat recurrent miscarriage. Journal of nanobiotechnology, 23(1), 780. https://doi.org/10.1186/s12951-025-03776-2
Makama, M., & Vogel, J. P. (2025). Atosiban and managing women in preterm labour. Lancet (London, England), 405(10483), 955–957. https://doi.org/10.1016/S0140-6736(25)00402-7
Mariavittoria L, Giovanni N, Marilena M, Raffaella I, Emilia S, et al. (2016) Two cycles of Atosiban in preventing preterm birth in twin pregnancies. Clin Obstet Gynecol Reprod Med 2: doi: 10.15761/COGRM.1000155
van der Windt, L. I., Klumper, J., Duijnhoven, R. G., Kok, M., Ris-Stalpers, C., de Boer, M. A., van Kaam, A. H., Pajkrt, E., Mol, B. W., Walker, K. F., McAuliffe, F. M., van der Post, J. A., Roos, C., Oudijk, M. A., & APOSTEL 8 Study Group (2025). Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial. Lancet (London, England), 405(10483), 1004–1013. https://doi.org/10.1016/S0140-6736(25)00295-8
Wang, R., Huang, H., Tan, Y., & Xia, G. (2023). Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis. Frontiers in endocrinology, 14, 1161707. https://doi.org/10.3389/fendo.2023.1161707
Xu, Y. J., Ran, L. M., Zhai, S. S., Luo, X. H., Zhang, Y. Y., Zhou, Z. Y., Liu, Y. H., Ren, L. D., Hong, T., & Liu, R. (2016). Evaluation of the efficacy of atosiban in pregnant women with threatened preterm labor associated with assisted reproductive technology. European review for medical and pharmacological sciences, 20(9), 1881–1887.
